Assessment of the validity of a population pharmacokinetic model for epirubicin-Reference-Cited by-同舟云学术

Assessment of the validity of a population pharmacokinetic model for epirubicin

Published:2006-07 Issue:1 Volume:62 Page:47-55
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ralph Lorraine D.,Sandstrom Marie,Twelves Chris,Dobbs Nicola A.,Thomson Alison H.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2006.02584.x/fullpdf

Reference19 articles.

1. A population model of epirubicin pharmacokinetics and application to dosage guidelines

2. Population Pharmacokinetics

3. 4 S Vozeh . Applications of Population Approach to Clinical Pharmacokinetics and Validation of the Results. New Strategies in Drug Development and Clinical Evaluation: the Population Approach. Luxemburg: Commission of the European Communities1991 : 107 -24 .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B;British Journal of Clinical Pharmacology;2023-09-12

2. Pharmacokinetic comparability between two populations using nonlinear mixed effect models: a Monte Carlo study;Journal of Pharmacokinetics and Pharmacodynamics;2023-01-28

3. Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg;Cancer Chemotherapy and Pharmacology;2022-07-14

4. Consideration of height‐based tobramycin dosing regimens for the treatment of adult cystic fibrosis pulmonary exacerbations;British Journal of Clinical Pharmacology;2021-12-23

5. Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses;Clinical Pharmacokinetics;2021-01-15